Nisa Investment Advisors’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.3K Buy
2,041
+2,033
+25,413% +$20.1K ﹤0.01% 2148
2026
Q1
$74 Hold
8
– – ﹤0.01% 3017
2025
Q4
$59 Hold
8
– – ﹤0.01% 2946
2025
Q3
$54 Hold
8
– – ﹤0.01% 2975
2025
Q2
$55 Sell
8
-297
-97% -$2.02K ﹤0.01% 3035
2025
Q1
$2.22K Hold
305
– – ﹤0.01% 2444
2024
Q4
$2.45K Hold
305
– – ﹤0.01% 2430
2024
Q3
$2.24K Buy
305
+287
+1,594% +$2.05K ﹤0.01% 2374
2024
Q2
$118 Sell
18
-70
-80% -$527 ﹤0.01% 2868
2024
Q1
$830 Buy
+88
New +$754 ﹤0.01% 2403
2023
Q1
– Sell
-3,400
Closed -$26K – 2724
2022
Q4
$26K Hold
3,400
– – ﹤0.01% 1982
2022
Q3
$22K Hold
3,400
– – ﹤0.01% 2030
2022
Q2
$18K Buy
3,400
+700
+26% +$3.77K ﹤0.01% 2079
2022
Q1
$13K Buy
+2,700
New +$12.5K ﹤0.01% 2157
2021
Q3
– Sell
-7,850
Closed -$56K – 2333
2021
Q2
$56K Buy
+7,850
New +$68K ﹤0.01% 1911

Other funds holding VMD

Nisa Investment Advisors's VMD Position: Q2 2026 in Review

Nisa Investment Advisors increased its Viemed Healthcare (VMD) stake by 25,413% in Q2 2026, buying an estimated $20.1K and bringing the position to 2,041 shares worth $23.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2148.

Nisa Investment Advisors first reported a position in VMD in Q2 2021 and has held it in 15 quarters since. The position peaked at $56K in Q2 2021. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Nisa Investment Advisors held 2,041 shares of Viemed Healthcare worth $23.3K as of Q2 2026.
  • Nisa Investment Advisors bought 2,033 Viemed Healthcare shares in Q2 2026, an estimated $20.1K.
  • Viemed Healthcare made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2148 holding.
  • Nisa Investment Advisors first reported a position in Viemed Healthcare in Q2 2021 and has held it in 15 quarters since.
  • Nisa Investment Advisors's Viemed Healthcare position peaked at $56K in Q2 2021.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.